NSAIDs suppress the expression of claudin-2 to promote invasion activity of cancer cells

被引:25
作者
Mima, Shinji [1 ]
Takehara, Masaya [1 ]
Takada, Hiroko [1 ]
Nishimura, Tomoko [1 ]
Hoshino, Tatsuya [1 ]
Mizushima, Tohru [1 ]
机构
[1] Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, Kumamoto 8620973, Japan
基金
日本科学技术振兴机构;
关键词
D O I
10.1093/carcin/bgn134
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Non-steroidal anti-inflammatory drugs (NSAIDs) show chemopreventive effects; however, the precise molecular mechanism of these effects is still unclear. On the other hand, the expression of proteins that form tight junctions (TJs) (such as claudins) in clinically isolated tumors is frequently altered relative to normal tissue. We previously reported that NSAIDs upregulate the expression of claudin-4 and that this upregulation contributes to NSAID-dependent inhibition of both migration activity and anchorageindependent growth of cancer cells. In the current study, we have systematically examined the effects of various NSAIDs on the expression of various TJ proteins and have found that NSAIDs specifically and drastically inhibit the expression of claudin-2. Overexpression or suppression of claudin-2 expression caused stimulation or inhibition, respectively, of the invasion and migration activity of cancer cells. Furthermore, NSAIDs inhibited the invasion and migration activity of cancer cells and this inhibition was suppressed by overexpression of claudin-2. In contrast, neither cell growth nor apoptosis induced by lack of anchorage of cancer cells was affected by overexpression or suppression of expression of claudin-2. These results suggest that inhibition of claudin-2 expression by NSAIDs contributes to NSAID-dependent inhibition of invasion of cancer cells in vitro and that it may be involved in the chemopreventive effects of NSAIDs by inhibiting metastasis in vivo.
引用
收藏
页码:1994 / 2000
页数:7
相关论文
共 39 条
[1]   Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity [J].
Agarwal, R ;
D'Souza, T ;
Morin, P .
CANCER RESEARCH, 2005, 65 (16) :7378-7385
[2]   Claudin-2 expression induces cation-selective channels in tight junctions of epithelial cells [J].
Amasheh, S ;
Meiri, N ;
Gitter, AH ;
Schöneberg, T ;
Mankertz, J ;
Schulzke, JD ;
Fromm, M .
JOURNAL OF CELL SCIENCE, 2002, 115 (24) :4969-4976
[3]   TIGHT JUNCTIONS AND THE MOLECULAR-BASIS FOR REGULATION OF PARACELLULAR PERMEABILITY [J].
ANDERSON, JM ;
VANITALLIE, CM .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1995, 269 (04) :G467-G475
[4]   Differential expression of claudin-2 in normal human tissues and gastrointestinal carcinomas [J].
Aung, PP ;
Mitani, Y ;
Sanada, Y ;
Nakayama, H ;
Matsusaki, K ;
Yasui, W .
VIRCHOWS ARCHIV, 2006, 448 (04) :428-434
[5]   Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer [J].
Dhawan, P ;
Singh, AB ;
Deane, NG ;
No, Y ;
Shiou, SR ;
Schmidt, C ;
Neff, J ;
Washington, MK ;
Beauchamp, RD .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (07) :1765-1776
[6]   UP-REGULATION OF CYCLOOXYGENASE-2 GENE-EXPRESSION IN HUMAN COLORECTAL ADENOMAS AND ADENOCARCINOMAS [J].
EBERHART, CE ;
COFFEY, RJ ;
RADHIKA, A ;
GIARDIELLO, FM ;
FERRENBACH, S ;
DUBOIS, RN .
GASTROENTEROLOGY, 1994, 107 (04) :1183-1188
[7]   Conversion of Zonulae occludentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells [J].
Furuse, M ;
Furuse, K ;
Sasaki, H ;
Tsukita, S .
JOURNAL OF CELL BIOLOGY, 2001, 153 (02) :263-272
[8]   Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2 [J].
Gupta, RA ;
DuBois, RN .
NATURE REVIEWS CANCER, 2001, 1 (01) :11-21
[9]   Prostaglandin E2 protects gastric mucosal cells from apoptosis via EP2 and EP4 receptor activation [J].
Hoshino, T ;
Tsutsumi, S ;
Tomisato, W ;
Hwang, HJ ;
Tsuchiya, T ;
Mizushima, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (15) :12752-12758
[10]   Comparison of cyclooxygenase-1 and -2 inhibitory activities of various nonsteroidal anti-inflammatory drugs using human platelets and synovial cells [J].
Kawai, S ;
Nishida, S ;
Kato, M ;
Furumaya, Y ;
Okamoto, R ;
Koshino, T ;
Mizushima, Y .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 347 (01) :87-94